CFO Tribune

Executive record

Kevin G. Sarney

Most recent record: Atara Biotherapeutics, Inc. names Kevin G. Sarney interim CFO (named as the incoming officer), effective June 26, 2026. See Atara Biotherapeutics, Inc..

1 verified record

This page lists only verified filing records that name Kevin G. Sarney; it is not a career history. Corrections: the corrections page.